Francois Chappuis is a specialist in neglected tropical diseases with the international group Doctors Without Borders.

VOA: special.2010.04.07

"This ruling is a setback for patients that will hinder medical progress for diseases without effective treatment options, " he said.

WSJ: Novartis Loses Glivec Patent Battle in India

"This ruling is a setback for patients that will hinder medical progress for diseases without effective treatment options, " said Ranjit Shahani, vice-chairman and managing director of Novartis India.

BBC: Novartis India case: Campaigners hail patent rejection

This reduces the inflammation associated with many diseases, including strokes and arthritis, without suppressing the immune system.

ECONOMIST: The way health claims about food are regulated is changing